Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Bink AB in connection with acquisition of Tailsweep
Mandate

Vinge advises Bink AB in connection with acquisition of Tailsweep

July 04, 2011

Vinge has advised Bink AB, the Bonnier Group’s sales undertaking for web-based media, in connection with the acquisition of Tailsweep AB. Since its formation in 2007, Tailsweep has managed to establish itself as Sweden’s largest advertising network in blogs and social media. The acquisition has allowed Blink to strengthen its product range within several market segments.

Vinge’s team consisted of partner Malin Leffler together with, among others, associates Jonas Bergström, Malin Buch and Fredrik Gustafsson. Partner Eva Fredrikson and associate Daniel Järmen provided IP and IT advice in the transaction.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026